Arkolith/Insider Trading/MRTX/Form 4

Christensen Jamie

EVP & Chief Scientific OfficerMirati Therapeutics, Inc. (MRTX) · full profile →Form 4 · filed Jan 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$94K
Net Open-Market Flow
-$94K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 16, 2024Sell(S)966$59.02$57K157K
Jan 16, 2024Sell(S)631$59.02$37K156K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-24-001690) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML